Tag:
Agennix
Latest Headlines
Latest Headlines
Agennix raises $13M for late-stage cancer trial
Agennix has raised $13 million in a private placement with existing shareholders. This is the first step of a plan to refinance the company. "The funds we have raised will enable us to continue
Italy's Cosmo to snap up BioXell in $41M deal
Faced with the fallout from a failed trial of its lead therapy, BioXell is following a familiar path taken by a lineup of European developers, agreeing to a buyout offer and joining forces with a
GPC, Agennix get $20M to fuel merger
Germany's GPC Biotech AG and Houston-based Agennix are planning to merge their oncology pipelines. In the deal, GPC is being merged into a new company which will have all of Agennix's shares along
